The latest update is out from Psyence Biomedical ( (PBM) ).
Psyence Biomedical Ltd. has announced a special meeting of shareholders scheduled for April 16, 2025, to discuss a proposed consolidation of the company’s common shares. The Board of Directors recommends shareholders vote in favor of this resolution, which is expected to impact the company’s share price and trading liquidity. The meeting will be held at WeirFoulds LLP in Toronto, and shareholders are encouraged to participate either in person or by proxy.
More about Psyence Biomedical
Psyence Biomedical Ltd. operates within the biomedical industry, focusing on innovative healthcare solutions. The company is involved in the development of products and services aimed at improving health outcomes, with a particular emphasis on leveraging scientific advancements.
YTD Price Performance: -69.81%
Average Trading Volume: 385,031
Technical Sentiment Signal: Buy
Current Market Cap: $2.46M
See more insights into PBM stock on TipRanks’ Stock Analysis page.